Skip to main content


Fig. 1 | Cardiovascular Diabetology

Fig. 1

From: A comparison between angiotensin converting enzyme inhibitors and angiotensin receptor blockers on end stage renal disease and major adverse cardiovascular events in diabetic patients: a population-based dynamic cohort study in Taiwan

Fig. 1

Flowchart of subject selection. LHDB longitudinal cohort of diabetes patients, DM diabetes mellitus, ACEi angiotensin converting enzyme inhibitors, ARB angiotensin receptor blockers, ESRD end stage renal disease, MACE major adverse cardiovascular events

Back to article page